Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 23, 2021 | Arch Oncology | $105.0M Series C | Joe Biller, CFA, Eric Pham, Joy Ghosh | Adage Capital Management, Avego Healthcare Capital, Broadfin Holdings, FMB Research, Point72, John McKearn, Roche |
| Mar 25, 2019 | Arch Oncology | $50.0M Series B | Rodger Riney | 3x5 Partners, John McKearn, Roche |